REGENERON PHARMACEUTICALS, - FDA APPROVES PASATRU (GARETOSMAB-GRTS) FOR ADULTS WITH FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

Reuters · 1d ago

Please log in to view news